“Despite the tremendous advances in surgical techniques, there are still patients with significant and difficult-to-control bleeding during surgery due to the increased use of multiple antiplatelet agents in many high risk and elderly patients,”
San Diego, CA (PRWEB) March 25, 2013
Paul Frohna, M.D., Ph.D., announced today the launch of a new website for his biotech consulting practice, Frohna Biotech Consulting, as well as his upcoming speaking engagement at the 2nd Annual International Symposium of Hematology in Xi’an, China.
New Site for Paul Frohna Consulting Services
The new Frohna Biotech Consulting website provides an overview of Dr. Frohna’s professional expertise and consulting services in his specialty areas of translational medicine, clinical pharmacology, and clinical and regulatory strategy. The site also includes Dr. Frohna’s blog as well as a guide to past and future speaking engagements.
Speaking Engagement in China
Dr. Frohna will be chairing a scientific session on Hemostasis and Thrombosis at the 2nd Annual International Symposium of Hematology--2013 conference in Xi’an, China on May 23-25, 2013.
In addition to chairing the session on May 24, Dr. Frohna will be making a presentation entitled "Advances in Topical Hemostats for Surgical Bleeding," which is an area of research expertise he has focused on while serving as the Chief Medical Officer of ProFibrix, Inc.
“Despite the tremendous advances in surgical techniques, there are still patients with significant and difficult-to-control bleeding during surgery due to the increased use of multiple antiplatelet agents in many high risk and elderly patients,” Dr. Frohna said. “So there is still a significant unmet medical need for faster and more effective agents to control surgical bleeding. With my presentation at this prestigious symposium, I hope to shed light on some of the novel agents that will hopefully become part of the arsenal for surgeons facing this challenge,” he added.
About Paul Frohna and Frohna Biotech Consulting
Paul Frohna, M.D., Ph.D., founded Frohna Biotech Consulting in 2008 in San Diego, Calif. to provide high-level and hands-on consulting services to biotechnology and pharmaceutical companies. Dr. Frohna provides services in translational medicine, clinical pharmacology and clinical and regulatory strategy for biologics, small molecules, and cell therapies across a wide range of therapeutic areas. He has been conducting clinical and translational research within the biotech industry since 2001. Frohna Biotech Consulting is on the web at http://www.paulfrohna.com and LinkedIn.